Skip to content

Is Barium Enema an Adequate Diagnostic Test for Patients With Positive FOBT?

Is Barium Enema an Adequate Diagnostic Test for Patients With Positive FOBT?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00619814
Acronym
DCBE
Enrollment
50
Registered
2008-02-21
Start date
2003-09-30
Completion date
2005-10-31
Last updated
2008-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Colon polyps, Fecal occult blood test, Double contrast barium enema, Colonoscopy

Brief summary

The research protocol aim is to compare diagnostic tools for the proper evaluation of patient with fecal occult blood test positive (FOBT +), a routine screening test for colorecatl carcinoma. The purpose of this study is to determine if Double Contrast Barium Enema (DCBE), a specialized radiographic exam of the colon, is a reasonable alternative for the evaluation of patients with positive fecal occult blood as compared to colonoscopy, which is considered the best evaluation method. Colonoscopy involves the direct visualization of the colon using a flexible instrument. This permits the removal of polyps and to obtain biopsies. It involves additional risks, discomfort and costs. In fact the DCBE is the experimental procedure in this protocol. Additional aims of this study are: to determine the localization, number, size and pathologic characteristics, if applicable, of findings in colonoscopy and/or DCBE and to determine the patient preference between both studies. This study is limited to those patients 50 years or older who are at average risk for colon cancer and who had a positive fecal occult blood screening test.

Interventions

PROCEDUREDouble-contrast Barium enema, colonoscopy

This is a blinded cohort study comparing double contrast barium enema (DCBE) and colonoscopy in detecting polyps and/or cancer in patients with positive FOBT. Initial evaluation consisted of complete clinical history and physical examination. A DCBE and a colonoscopy were performed in all patients. All polyps identified during colonoscopy were removed and classified by histology. Sensitivity and specificity of DCBE for polyp and/or cancer detection was determined. Tolerability and grade of satisfaction with study procedures was assessed.

Sponsors

VA Caribbean Healthcare System
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Asymptomatic patients older than 50 years of age, with at least one positive FOBT * Without history of colon cancer and/or polyps * Gross gastrointestinal bleeding or prior colonoscopy or DCBE * Who were willing to participate in the study * Were included in the investigation.

Exclusion criteria

* Patients with poor cardio-respiratory condition * Coagulation deficiency, use of anticoagulants or other drugs affecting coagulation * Severe renal or liver disease * Hospitalized patients and palpable abdominal or rectal mass were excluded from the study.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026